Alessandro Santin: This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients

Yale Cancer Center made the following post on X:

“Led by Dr. Alessandro Santin and researchers at Yale Cancer Center, the TROPiCS-03 phase II study for patients with advanced or recurrent endometrial cancer has advanced to a phase III trial. ‘This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients,’ said Dr. Santin.”